Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. (Q46424938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Edward Frank Knol

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Oldhoff JM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Darsow U

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Werfel T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Katzer K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Wulf A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Laifaoui J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Plötz S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Kapp A

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Bruijnzeel-Koomen CA

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ring J

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

de Bruin-Weller MS

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

693-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813818%20AND%20SRC:MED&resulttype=core&format=json

Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Development of IL-5 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00791.X